Decision-Making around Psychedelics for Depression and Anxiety: a Model Based on Online Discussions
International Journal of Mental Health and Addiction April 1, 2024 David T. Kryszajtys, Jacqueline L. Bender, Brian Rush et al. 2 citations
People who use psychedelics to self-treat depression and anxiety often arrive at that decision after being dissatisfied with standard mental health care. An analysis of 98 posts from online discussion threads revealed a four-stage decision-making process: first, frustration with conventional treatment; second, exploring limited information about psychedelic options; third, trial-and-error use despite safety uncertainties; and fourth, either continuing or stopping self-treatment. Those who continued adapted their practices over time. Decisions were guided by personal and peers' experiences rather than scientific evidence, and many avoided healthcare and official sources due to stigma and legal concerns. The findings suggest a need for user-informed decisional support to reduce harm.